BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36756386)

  • 1. Thirdhand Smoke May Promote Lung Adenocarcinoma Development through HN1.
    Peng J; Shuopeng J; Wang H; Wang X; Wang L
    Comput Math Methods Med; 2023; 2023():3407313. PubMed ID: 36756386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Wang J; Zhan X
    Front Immunol; 2021; 12():752643. PubMed ID: 34887858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of thirdhand smoke to overall tobacco smoke exposure in pediatric patients: study protocol.
    Mahabee-Gittens EM; Matt GE; Hoh E; Quintana PJE; Stone L; Geraci MA; Wullenweber CA; Koutsounadis GN; Ruwe AG; Meyers GT; Zakrajsek MA; Witry JK; Merianos AL
    BMC Public Health; 2019 May; 19(1):491. PubMed ID: 31046729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Susceptibility to Thirdhand-Smoke-Induced Lung Cancer Development.
    Hang B; Mao JH; Snijders AM
    Nicotine Tob Res; 2019 Aug; 21(9):1294-1296. PubMed ID: 29917126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When smokers quit: exposure to nicotine and carcinogens persists from thirdhand smoke pollution.
    Matt GE; Quintana PJE; Zakarian JM; Hoh E; Hovell MF; Mahabee-Gittens M; Watanabe K; Datuin K; Vue C; Chatfield DA
    Tob Control; 2016 Sep; 26(5):548-556. PubMed ID: 27655249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thirdhand cigarette smoke in an experimental chamber: evidence of surface deposition of nicotine, nitrosamines and polycyclic aromatic hydrocarbons and de novo formation of NNK.
    Schick SF; Farraro KF; Perrino C; Sleiman M; van de Vossenberg G; Trinh MP; Hammond SK; Jenkins BM; Balmes J
    Tob Control; 2014 Mar; 23(2):152-9. PubMed ID: 23716171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
    Yu H; Pang Z; Li G; Gu T
    J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
    Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y
    BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma.
    Tian Y; Yu M; Sun L; Liu L; Wang J; Hui K; Nan Q; Nie X; Ren Y; Ren X
    J Comput Biol; 2020 Jul; 27(7):1067-1078. PubMed ID: 31750732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
    Meng F; Zhang L; Ren Y; Ma Q
    J Cell Physiol; 2019 Jul; 234(7):10918-10925. PubMed ID: 30549039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Casino goes smoke free: a longitudinal study of secondhand and thirdhand smoke pollution and exposure.
    Matt GE; Quintana PJE; Hoh E; Zakarian JM; Chowdhury Z; Hovell MF; Jacob P; Watanabe K; Theweny TS; Flores V; Nguyen A; Dhaliwal N; Hayward G
    Tob Control; 2018 Nov; 27(6):643-649. PubMed ID: 29439207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
    Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
    PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a method for quantification of two tobacco-specific nitrosamines in indoor air.
    Gómez Lueso M; Mitova MI; Mottier N; Schaller M; Rotach M; Goujon-Ginglinger CG
    J Chromatogr A; 2018 Dec; 1580():90-99. PubMed ID: 30391037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirdhand smoke and exposure in California hotels: non-smoking rooms fail to protect non-smoking hotel guests from tobacco smoke exposure.
    Matt GE; Quintana PJ; Fortmann AL; Zakarian JM; Galaviz VE; Chatfield DA; Hoh E; Hovell MF; Winston C
    Tob Control; 2014 May; 23(3):264-72. PubMed ID: 23669058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network module function enrichment analysis of lung squamous cell carcinoma and lung adenocarcinoma.
    Li P; Yuan H; Kuang X; Zhang T; Ma L
    Medicine (Baltimore); 2022 Nov; 101(47):e31798. PubMed ID: 36451444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.
    Hou G; Lu Z; Bi Y; Deng J; Yang X
    Med Oncol; 2022 Feb; 39(5):51. PubMed ID: 35150321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thirdhand Smoke at Philip Morris.
    Whitlatch A; Schick S
    Nicotine Tob Res; 2019 Nov; 21(12):1680-1688. PubMed ID: 30053240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.